4.13.12Hyperion Therapeutics Files Registration Statement for Proposed Initial Public Offering
3.22.12Hyperion Therapeutics Acquires Ravicti™ (glycerol phenylbutyrate) from Ucyclyd Pharma, Inc.
Recent Press Releases
